176 related articles for article (PubMed ID: 29709563)
1. Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions.
Smith JL; Sheridan K; Parkins CJ; Frueh L; Jemison AL; Strode K; Dow G; Nilsen A; Hirsch AJ
Antiviral Res; 2018 Jul; 155():12-19. PubMed ID: 29709563
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
[TBL] [Abstract][Full Text] [Related]
3. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.
Smith JL; Stein DA; Shum D; Fischer MA; Radu C; Bhinder B; Djaballah H; Nelson JA; Früh K; Hirsch AJ
J Virol; 2014 May; 88(10):5533-42. PubMed ID: 24599995
[TBL] [Abstract][Full Text] [Related]
5. A novel inhibitor of dengue virus replication that targets the capsid protein.
Byrd CM; Dai D; Grosenbach DW; Berhanu A; Jones KF; Cardwell KB; Schneider C; Wineinger KA; Page JM; Harver C; Stavale E; Tyavanagimatt S; Stone MA; Bartenschlager R; Scaturro P; Hruby DE; Jordan R
Antimicrob Agents Chemother; 2013 Jan; 57(1):15-25. PubMed ID: 23070172
[TBL] [Abstract][Full Text] [Related]
6. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin.
Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G
Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141
[TBL] [Abstract][Full Text] [Related]
7. A cocrystal structure of dengue capsid protein in complex of inhibitor.
Xia H; Xie X; Zou J; Noble CG; Russell WK; Holthauzen LMF; Choi KH; White MA; Shi PY
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17992-18001. PubMed ID: 32669438
[TBL] [Abstract][Full Text] [Related]
8. A Targeted Computational Screen of the SWEETLEAD Database Reveals FDA-Approved Compounds with Anti-Dengue Viral Activity.
Moshiri J; Constant DA; Liu B; Mateo R; Kearnes S; Novick P; Prasad R; Nagamine C; Pande V; Kirkegaard K
mBio; 2020 Nov; 11(6):. PubMed ID: 33173007
[TBL] [Abstract][Full Text] [Related]
9. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545.
Modhiran N; Gandhi NS; Wimmer N; Cheung S; Stacey K; Young PR; Ferro V; Watterson D
Antiviral Res; 2019 Aug; 168():121-127. PubMed ID: 31085206
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo.
Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029
[TBL] [Abstract][Full Text] [Related]
12. Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.
Balinsky CA; Schmeisser H; Ganesan S; Singh K; Pierson TC; Zoon KC
J Virol; 2013 Dec; 87(24):13094-106. PubMed ID: 24027323
[TBL] [Abstract][Full Text] [Related]
13. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of ST081006 against the dengue virus.
Lee JK; Chui JLM; Lee RCH; Kong HY; Chin WX; Chu JJH
Antiviral Res; 2019 Nov; 171():104589. PubMed ID: 31421165
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
[TBL] [Abstract][Full Text] [Related]
17. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
18. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
[TBL] [Abstract][Full Text] [Related]
19. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
20. Betulinic acid exhibits antiviral effects against dengue virus infection.
Loe MWC; Hao E; Chen M; Li C; Lee RCH; Zhu IXY; Teo ZY; Chin WX; Hou X; Deng J; Chu JJH
Antiviral Res; 2020 Dec; 184():104954. PubMed ID: 33080251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
